Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro

References

• HolmdahlLRisbergBAdhesions: prevention and complications in general surgeryEur J Surg199716331691749085057
   PubMedGoogle Scholar
• SchnürigerBBarmparasGBrancoBCLustenbergerTInabaKDemetriadesDPrevention of postoperative peritoneal adhesions: a review of the literatureAm J Surg2011201111112120817145
   PubMedGoogle Scholar
• De VrieseASTiltonRGMortierSLameireNHMyofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemiaNephrol Dial Transplant20062192549255516757496
   PubMedGoogle Scholar
• López-CabreraMAguileraAAroeiraLSEx vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failurePerit Dial Int2006261263416538870
   PubMedGoogle Scholar
• De VrieseASThe John F. Maher Recipient Lecture 2004: Rage in the peritoneumPerit Dial Int200525181115770917
   PubMedGoogle Scholar
• Jiménez-HeffernanJAAguileraAAroeiraLSImmunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosisVirchows Arch2004444324725614749928
   PubMedGoogle Scholar
• BolandGMWeigelRJFormation and prevention of postoperative abdominal adhesionsJ Surg Res2006132131216457846
   PubMed Web of Science ®Google Scholar
• AaronsCBCohenPAGowerAStatins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activityAnn Surg2007245217618417245169
   PubMed Web of Science ®Google Scholar
• LiakakosTThomakosNFinePMDervenisCYoungRLPeritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and managementDig Surg200118426027311528133
   PubMed Web of Science ®Google Scholar
• CheongYCLairdSMLiTCSheltonJBLedgerWLCookeIDPeritoneal healing and adhesion formation/reformationHum Reprod Update20017655656611727864
   PubMed Web of Science ®Google Scholar
• FalkKBjörquistPStrömqvistMHolmdahlLReduction of experimental adhesion formation by inhibition of plasminogen activator inhibitor type 1Br J Surg200188228628911167882
   PubMedGoogle Scholar
• BrantonMHKoppJBTGF-beta and fibrosisMicrobes Infect19991151349136510611762
   PubMed Web of Science ®Google Scholar
• HolmdahlLKotseosKBergströmMFalkPIvarssonMLCheginiNOverproduction of transforming growth factor-beta1 (TGF-beta1) is associated with adhesion formation and peritoneal fibrinolytic impairmentSurgery2001129562663211331455
   PubMedGoogle Scholar
• CheginiNKotseosKZhaoYDifferential expression of TGF-beta1 and TGF-beta3 in serosal tissues of human intraperitoneal organs and peritoneal adhesionsHum Reprod20011661291130011387308
   PubMed Web of Science ®Google Scholar
• DongXDongJZhangRFanLLiuLWuGAnti-inflammatory effects of tanshinone IIA on radiation-induced microglia BV-2 cells inflammatory responseCancer Biother Radiopharm200924668168720025548
   PubMedGoogle Scholar
• CaoEHLiuXQWangJJXuNFEffect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cellsFree Radic Biol Med19962068018068728027
   PubMed Web of Science ®Google Scholar
• FangJXuSWWangPTanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertensionPhytomedicine2010181586420638255
   PubMedGoogle Scholar
• WangCLiXMengXZhouJQinFHouLPrevention of experimental postoperative peritoneal adhesions through the intraperitoneal administration of tanshinone IIAPlanta Med2014801296997325089738
   PubMedGoogle Scholar
• YuXYLinSGZhouZWRole of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza BungeCurr Drug Metab20078432534017504222
   PubMed Web of Science ®Google Scholar
• LiuJZhuJDuZQinBPreparation and pharmacokinetic evaluation of Tashinone IIA solid lipid nanoparticlesDrug Dev Ind Pharm200531655155616109628
   PubMed Web of Science ®Google Scholar
• HaoHWangGCuiNLiJXieLDingZPharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersionPlanta Med200672141311131717024606
   PubMed Web of Science ®Google Scholar
• LiHLZhangZYMaLLChenXYPreparation of tanshinone micro-emulsion and its absorption in rat intestine in situZhongguo Zhong Yao Za Zhi2007321110241027 Chinese17672333
   PubMedGoogle Scholar
• DateAANagarsenkerMSParenteral microemulsions: an overviewInt J Pharm20083551–2193018295991
   PubMed Web of Science ®Google Scholar
• LiXQinFYangLMoLLiLHouLSulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinomaInt J Nanomedicine201493971398525170267
   PubMed Web of Science ®Google Scholar
• ChuTZhangQLiHDevelopment of intravenous lipid emulsion of tanshinone IIA and evaluation of its anti-hepatoma activity in vitroInt J Pharm20124241–2768822226873
   PubMedGoogle Scholar
• LanzaGMWallaceKDScottMJA novel site-targeted ultrasonic contrast agent with broad biomedical applicationCirculation19969412333433408989148
   PubMed Web of Science ®Google Scholar
• NairSKBhatIKAuroraALRole of proteolytic enzyme in the prevention of postoperative intraperitoneal adhesionsArch Surg197410868498534829809
   PubMedGoogle Scholar
• LimRMorrillJMPrushikSGAn FDA approved neurokinin-1 receptor antagonist is effective in reducing intraabdominal adhesions when administered intraperitoneally, but not orallyJ Gastrointest Surg200812101754176118709513
   PubMed Web of Science ®Google Scholar
• de HinghIHde ManBMLommeRMvan GoorHHendriksTColonic anastomotic strength and matrix metalloproteinase activity in an experimental model of bacterial peritonitisBr J Surg200390898198812905552
   PubMed Web of Science ®Google Scholar
• di ZeregaGSCampeauJDPeritoneal repair and post-surgical adhesion formationHum Reprod Update20017654755511727863
   PubMedGoogle Scholar
• CollenDLijnenHRMolecular basis of fibrinolysis, as relevant for thrombolytic therapyThromb Haemost19957411671718578451
   PubMedGoogle Scholar
• CollenDOn the regulation and control of fibrinolysis. Edward Kowalski Memorial LectureThromb Haemost198043277896450468
   PubMed Web of Science ®Google Scholar
• de BoerJPAbbinkJJBrouwerMCPAI-1 synthesis in the human hepatoma cell line HepG2 is increased by cytokines – evidence that the liver contributes to acute phase behaviour of PAI-1Thromb Haemost19916521811851711245
   PubMedGoogle Scholar
• KruithofEKTran-ThangCRansijnABachmannFDemonstration of a fast-acting inhibitor of plasminogen activators in human plasmaBlood19846449079136434006
   PubMedGoogle Scholar
• van MourikJALawrenceDALoskutoffDJPurification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cellsJ Biol Chem19842592314914149216438106
   PubMedGoogle Scholar
• SeguraTSchmokelHHubbellJARNA interference targeting hypoxia inducible factor 1alpha reduces post-operative adhesions in ratsJ Surg Res2007141216217017561118
   PubMedGoogle Scholar
• BrochhausenCSchmittVHPlanckCNCurrent strategies and future perspectives for intraperitoneal adhesion preventionJ Gastrointest Surg20121661256127422297658
   PubMedGoogle Scholar
• FriedmanSLHepatic fibrosis – overviewToxicology2008254312012918662740
   PubMed Web of Science ®Google Scholar
• HobsonKGDeWingMHoHSWolfeBMChoKGreenhalghDGExpression of transforming growth factor beta1 in patients with and without previous abdominal surgeryArch Surg2003138111249125214609876
   PubMedGoogle Scholar
• TahashiYMatsuzakiKDateMDifferential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injuryHepatology2002351496111786959
   PubMed Web of Science ®Google Scholar
• DerynckRZhangYESmad-dependent and Smad-independent pathways in TGF-beta family signallingNature2003425695857758414534577
   PubMed Web of Science ®Google Scholar
• YangYYangSChenMZhangXZouYZhangXCompound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblastsJ Ethnopharmacol2008118226427018502066
   PubMedGoogle Scholar